Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

被引：0
|
作者：
Ng, Wern Lynn [1 ]
Bock, Allison M. [2 ]
Kovalenko, Iuliia [1 ]
Wert, Yijin [1 ]
Ng, Lay She [3 ]
Wang, Yucai [4 ]
Nowakowski, Grzegorz S. [4 ]
机构：
[1] UPMC Harrisburg, Harrisburg, PA USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Royal Coll Surg Ireland & Univ Coll Dublin Malays, George Town, Malaysia
[4] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3829 / 3830
页数：2
相关论文
共 50 条
  • [21] Treatment of primary mediastinal large B-cell lymphoma with immunochemotherapy.
    Tabacof, J
    Yana, NAS
    BLOOD, 2005, 106 (11) : 267B - 268B
  • [22] The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma
    Yoon, Sang Eun
    Kang, Woorim
    Choi, Seunghyun
    Park, Yoon
    Chalita, Mauricio
    Kim, Hyun
    Lee, Je Hee
    Hyun, Dong-Wook
    Ryu, Kyung Ju
    Sung, Hojun
    Lee, Jae-Yun
    Bae, Jin-Woo
    Kim, Won Seog
    Kim, Seok Jin
    BLOOD, 2023, 141 (18) : 2224 - 2238
  • [23] Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology
    Lee, Jeong Hoon
    Song, Ga-Young
    Lee, Jonghyun
    Kang, Sae-Ryung
    Moon, Kyoung Min
    Choi, Yoo-Duk
    Shen, Jeanne
    Noh, Myung-Giun
    Yang, Deok-Hwan
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2024, 10 (03):
  • [24] Immunochemotherapy RCHOP in patients with diffuse large B-cell lymphoma over 75 year old.
    Paszkiewicz-Kozik, Ewa
    Romejko-Jarosinska, Joanna
    Osowiecki, Michal
    Becht, Rafal
    Swierkowska-Czeneszew, Monika
    Domanska-Czyz, Katarzyna
    Ostrowska, Beata
    Poplawska, Lidia
    Rymkiewicz, Grzegorz
    Walewski, Jan Andrzej
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma
    Harris, Will
    Bataillard, Edward J.
    Choi, Yoonha
    El-Galaly, Tarec C.
    Cuchelkar, Vaikunth
    Henneges, Carsten
    Kwan, Antonia
    Schneider, Daniel J.
    Paulson, Joseph N.
    Nielsen, Tina G.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [26] Survivin expression in patients with newly diagnosed nodal diffuse large B-cell lymphoma treated with immunochemotherapy
    Cemerikic-Martinovic, V.
    Markovic, O.
    Marisavljevic, D.
    Martinovic, T.
    Andjelkovic, N.
    Djurdjevic, P.
    VIRCHOWS ARCHIV, 2012, 461 : S196 - S197
  • [27] Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Lanic, Helene
    Kraut-Tauzia, Jerome
    Modzelewski, Romain
    Clatot, Florian
    Mareschal, Sylvain
    Picquenot, Jean Michel
    Stamatoullas, Aspasia
    Lepretre, Stephane
    Tilly, Herve
    Jardin, Fabrice
    LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 817 - 823
  • [28] Muscle Loss During Immunochemotherapy for Diffuse Large B-Cell Lymphoma and its Clinical and Prognostic Associations
    Lucijanic, Marko
    Korunic, Renata Huzjan
    Sedinic, Martina
    Kusec, Rajko
    Pejsa, Vlatko
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S376 - S376
  • [29] IMMUNOCHEMOTHERAPY-INDUCED CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESPONSE TO ZOFENOPRIL
    Samura, B.
    HAEMATOLOGICA, 2013, 98 : 650 - 651
  • [30] Prognostic Impact of Extranodal Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy and PET/CT Staging
    El-Galaly, Tarec Christoffer
    Villa, Diego
    Alzahrani, Musa
    Hansen, Jakob Werner
    Sehn, Laurie H.
    Wilson, Don
    Brown, Peter de Nully
    Loft, Annika
    Iyer, Victor
    Johnsen, Hans Erik
    Savage, Kerry J.
    Connors, Joseph M.
    Hutchings, Martin
    BLOOD, 2014, 124 (21)
12345